BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 26750626)

  • 21. Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.
    Harutyunyan NM; Vardanyan S; Ghermezi M; Gottlieb J; Berenson A; Andreu-Vieyra C; Berenson JR
    Br J Haematol; 2016 Jul; 174(1):81-7. PubMed ID: 27017948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
    Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
    Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of the assessment of heavy/light chain pairs of immunoglobulin in monoclonal gammopathies].
    Ščudla V; Pika T; Minařík J
    Vnitr Lek; 2015 Jan; 61(1):60-1, 63-71. PubMed ID: 25693618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
    Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
    Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of immunoglobulin heavy/light chain detection on the minimal residual disease monitoring in IgG multiple myeloma patients].
    Zhang H; Zhou L; Li R; He J; Peng Z; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):95-8. PubMed ID: 25778881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.
    Boyle E; Manier S; Lejeune J; Fouquet G; Guidez S; Bonnet S; Debarri H; Demarquette H; Dulery R; Gay J; Hennache B; Onraed B; Faucompré JL; Schraen S; Facon T; Avet-Loiseau H; Chevret S; Leblond V; Harding S; Leleu X
    Clin Cancer Res; 2016 Oct; 22(20):5152-5158. PubMed ID: 27169996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports.
    Gagliardi A; Carbone C; Russo A; Cuccurullo R; Lucania A; Cioppa PD; Misso G; Caraglia M; Tommasino C; Mastrullo L
    Oncol Lett; 2016 Oct; 12(4):2363-2370. PubMed ID: 27698801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heavy/light chain assay as a biomarker for diagnosis and follow-up of multiple myeloma.
    Chae H; Han E; Yoo J; Lee J; Lee JJ; Cha K; Kim M; Kim Y; Lee SE; Min CK
    Clin Chim Acta; 2018 Apr; 479():7-13. PubMed ID: 29324245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
    Isola I; Moreno DF; Moga E; Mena MP; Tovar N; Rodríguez-Lobato LG; Oliver-Caldés A; Salgado MC; Brasó-Maristany F; Yagüe J; Cibeira MT; Prat A; Rosiñol L; Bladé J; Fernández de Larrea C
    Ann Hematol; 2021 Dec; 100(12):2997-3005. PubMed ID: 34463804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical sensitivity and diagnostic performance of serum protein electrophoresis on the HYDRAGEL 30 PROTEIN(E) β1-β2 Sebia Hydrasys system.
    Tsui AKY; Thomas D; Hunt A; Estey M; Christensen CL; Higgins T; Sandhu I; Rodriguez-Capote K
    Clin Biochem; 2018 Jan; 51():80-84. PubMed ID: 28916438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
    Cao F; Zhang R; Xu L; Liu M; Yuan Y
    Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
    Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
    Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
    Ermak N; Nguyen-Khoa T; Alyanakian MA
    Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.
    Kraj M
    Adv Clin Exp Med; 2014; 23(1):127-33. PubMed ID: 24596015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new approach for rapid detection and typing of serum monoclonal components.
    Cacoub P; Camproux AC; Thiolières JM; Assogba U; Hausfater P; Mallet A; Foglietti MJ; Piette JC; Bernard M
    Clin Chim Acta; 2000 Dec; 302(1-2):105-24. PubMed ID: 11074068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic performance of κ/λ serum free light chain ratio (Freelite® assay) and IgGκ/IgGλ ratio (Hevylite® assay) as prognostic biomarkers of the evolution of immune thrombocytopenia into a chronic disease in adult patients].
    Martellosio JP; Barra A; Roy-Peaud F; Souchaud-Debouverie O; Martin M; Lateur C; Gombert JM; Roblot P; Puyade M
    Rev Med Interne; 2020 Jan; 41(1):3-7. PubMed ID: 31722837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological variation of immunoglobulin heavy chain-light chain pairs in serum.
    Finlay JA; Wu AH
    Clin Chim Acta; 2014 Sep; 436():68-71. PubMed ID: 24824555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.